ED Coding & Reimbursement Alert - 2005 Issue 34
DME: Proposed Dispensing Cut Leaves Suppliers Gasping
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s proposed review of the Medicare dispensing fee for home inhalation drug therapy, including the agency’s stated rationale, the comment process, and reactions from homecare suppliers and industry advocates. It is relevant to DME suppliers, respiratory providers, homecare organizations, and coders or reimbursement professionals tracking Medicare payment policy and inhalation drug coverage issues.
Why This Topic Matters
Medicare payment policy changes can directly affect supplier reimbursement, access to inhalation drug therapy, and operational planning for homecare and respiratory providers. This piece helps readers understand the scope of the proposed fee review, the organizations involved, and the timing of CMS’s rulemaking process.
What You Will Learn
- The general focus of CMS’s proposed review of a Medicare dispensing fee
- How stakeholder comments are part of the rulemaking process
- Which provider groups and industry organizations are responding to the proposal
- What broader reimbursement and access concerns are being raised by suppliers
- The timeline for the proposed rule, comment period, and final rule publication
Who Should Read This
- Durable medical equipment suppliers
- Respiratory providers
- Homecare organizations
- Medical coding and billing professionals
- Reimbursement and compliance staff
- Health policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com